Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

112.62 +0.86 (+0.77%)
Official Closing Price Updated: 7:00 PM EDT, Oct 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Marjorie Taylor Greene Stays Loyal To Trump, Keeps DJT Stock, Buys Into Warren Buffett's Berkshire In Latest Trades
Marjorie Taylor Green's investment portfolio includes bets on technology, Warren Buffett and Donald Trump. 
Via Benzinga
Topics Government
Exposures Political
Why NYSE:CAH provides a good dividend, while having solid fundamentals.
Why CARDINAL HEALTH INC (NYSE:CAH) is a Top Pick for Dividend Investors. 
Via Chartmill
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Cardinal Health, Inc. Dividend Stock Analysis
Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies and related products to a broad range of health care customers. 
Via Talk Markets
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years
Via Benzinga
Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings
Via Benzinga
How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings
Via Benzinga
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives. 
Via Benzinga
Opioid Settlement: Drug Distributors McKesson, Cencora, Cardinal Health To Pay $300M To Health Insurers
Three major U.S. drug distributors, McKesson, Cencora, and Cardinal Health, have agreed to a $300 million settlement over claims by health insurers and benefit plans that they contributed to the opioid... 
Via Benzinga
Cardinal Health Stock Sees Relative Strength Rating Climb To 71
In a welcome move, Cardinal Health stock saw its Relative Strength Rating improve from 63 to 71 on Wednesday. 
Via Investor's Business Daily
How To Build A Dividend Growth Portfolio In An Overpriced Market
The stock market as measured by the S&P is currently at an all-time high which makes it very challenging to try to build a quality dividend growth portfolio. 
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Companies Reporting Remarkable Results: Walmart, Eli Lilly, Cardinal Health
Several companies have stolen the spotlight throughout the earnings period, including Walmart, Cardinal Health, and Eli Lilly. All three posted robust results and upped guidance, as shares of each... 
Via Talk Markets
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
Via Benzinga
How Is The Market Feeling About Cardinal Health?
Via Benzinga
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Wall Street Battles For Fifth Day Of Gains As Inflation Cools, Gives Green Light To Rate Cuts; Financials Outperform: What's Driving Markets Wednesday?
The July consumer inflation report released Wednesday confirmed a continued cooling trend in price increases across the economy, with the headline Consumer Price Index (CPI) coming in at 2.9%... 
Via Benzinga
Topics Economy
Exposures Economy Interest Rates
Stocks To Watch Today: Alphabet, Cardinal Health, And Kellanova
Alphabet faces a potential breakup by the DOJ, causing its shares to tumble; Cardinal Health rises on strong earnings and improved guidance; and Kellanova surges following news of its acquisition by... 
Via Talk Markets
CAH Stock Earnings: Cardinal Health Beats EPS, Beats Revenue for Q4 2024
CAH stock results show that Cardinal Health beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
S&P 500 Rises, Small Caps Outperform As July Consumer Price Index Fuels Fed Rate Cut Hopes: 5 ETFs to Watch Wednesday
US inflation eases in July, keeping Fed rate cut hopes alive. Stocks rise, yields stable, dollar gains against yen. Tech and small caps outperform. 
Via Benzinga
Topics ETFs Economy Stocks
Exposures Interest Rates US Equities
Cardinal Health Reports Double Beat In Fiscal Q4
Cardinal Health has reported impressive fourth-quarter and fiscal year 2024 results, surpassing market expectations. 
Via Talk Markets
Top 3 Health Care Stocks That May Crash In August
Via Benzinga
Cardinal Health Poised To Retake Key Level On Bullish Fiscal 2025 View
Cardinal Health reported better-than-expected fiscal fourth-quarter earnings and hiked 2025 profit expectations 
Via Investor's Business Daily
Pharma Distribution Giant Cardinal Health Lifts 2025 Guidance After Q4 Earnings Beat, Raises Stock Buyback Expectation By $250M
Cardinal Health reports Q4 2024 EPS of $1.84, beating estimates. Sales surged 12% to $59.87 billion, driven by strong pharmaceutical and medical segment growth. The company raises FY 2025 EPS guidance... 
Via Benzinga
Topics Earnings
Exposures Financial
Wall Street Set For Subdued Start As Traders Await All-Important Inflation Data, Bitcoin Tops $61K: Fund Manager Flags This Event As Pivotal To Near-term Market Recovery
The major index futures are pointing to a nervous start ahead of the consumer price inflation report that is due at 8:30 a.m. EDT. Bond yields are slipping ahead of the inflation data. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Nasdaq, Dow Jones Jump Over 400 Points Following PPI Report: Investor Sentiment Improves But Greed Index Remains In 'Extreme Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Brinker International, Cisco And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Health Care Giant McKesson Dives Amid Big Revenue Miss
McKesson earnings beat estimates, but the drug and health supplies distribution giant badly missed sales estimates. MCK stock dived. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
Via MarketBeat
Topics Supply Chain
Exposures Supply Chain
The 7 Most Undervalued Dividend Stocks to Buy in July 2024
For nearly 100 years income stocks have outperformed the market and these three undervalued dividend stocks are your best buys this month. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.